José María Del Campo

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

Nicoletta Colombo, Carien L. Creutzberg, Frédéric Amant et al. · Annals of Oncology · 2015 · 1.4K citations · Full text

Gynecological Surgery, Medicine, Gynecology +6

Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments.

Joan Albanell, Jordi Codony‐Servat, Federico Rojo et al. · PubMed · 2001 · 275 citations

Epidermal Growth Factor, Extracellular Signal-regulated Kinases, Pathology +19

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

Andreas du Bois, Gunnar B. Kristensen, Isabelle Ray‐Coquard et al. · The Lancet Oncology · 2015 · 207 citations · Full text

Placebo-controlled Phase 3, Medicine, Metronomic Therapy +9

Review of coastal Land Reclamation situation in the World

Mario Martín-Antón, Vicente Negro, José María Del Campo et al. · Journal of Coastal Research · 2016 · 108 citations

Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases

Rámón Colomer, Álvaro Ruibal, J Genollá et al. · Breast Cancer Research and Treatment · 1989 · 102 citations

Breast Oncology, Breast Cancer Patients, Ca 15-3 Levels +9